THOUSAND OAKS, Calif. Biotech giant Amgen has appointed a former Novartis executive to its board, Amgen said Thursday.
The company announced the appointment of Jonathan Peacock as CFO and EVP, effective Sept. 1. In the new position, Peacock will be responsible for finance and investor relations. He previously had served as Novartis Pharmaceutical’s CFO and administration officer since 2005.
“I am delighted to have a leader of Jonathan’s talent, vision and international experience join Amgen at a time when we are expanding globally,” chairman and CEO Kevin Sharer said.